Cargando…

Restricted autologous lymphocytotoxicity in lung neoplasia.

Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Vose, B. M., Vánky, F., Fopp, M., Klein, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1978
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009731/
https://www.ncbi.nlm.nih.gov/pubmed/81674
_version_ 1782136175351300096
author Vose, B. M.
Vánky, F.
Fopp, M.
Klein, E.
author_facet Vose, B. M.
Vánky, F.
Fopp, M.
Klein, E.
author_sort Vose, B. M.
collection PubMed
description Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours.
format Text
id pubmed-2009731
institution National Center for Biotechnology Information
language English
publishDate 1978
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20097312009-09-10 Restricted autologous lymphocytotoxicity in lung neoplasia. Vose, B. M. Vánky, F. Fopp, M. Klein, E. Br J Cancer Research Article Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours. Nature Publishing Group 1978-09 /pmc/articles/PMC2009731/ /pubmed/81674 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Vose, B. M.
Vánky, F.
Fopp, M.
Klein, E.
Restricted autologous lymphocytotoxicity in lung neoplasia.
title Restricted autologous lymphocytotoxicity in lung neoplasia.
title_full Restricted autologous lymphocytotoxicity in lung neoplasia.
title_fullStr Restricted autologous lymphocytotoxicity in lung neoplasia.
title_full_unstemmed Restricted autologous lymphocytotoxicity in lung neoplasia.
title_short Restricted autologous lymphocytotoxicity in lung neoplasia.
title_sort restricted autologous lymphocytotoxicity in lung neoplasia.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009731/
https://www.ncbi.nlm.nih.gov/pubmed/81674
work_keys_str_mv AT vosebm restrictedautologouslymphocytotoxicityinlungneoplasia
AT vankyf restrictedautologouslymphocytotoxicityinlungneoplasia
AT foppm restrictedautologouslymphocytotoxicityinlungneoplasia
AT kleine restrictedautologouslymphocytotoxicityinlungneoplasia